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The selective removal of undesired or damaged mitochondria by autophagy, known as
mitophagy, is crucial for cellular homoeostasis, and prevents tumour diffusion, neurode-
generation and ageing. The pro-autophagic molecule AMBRA1 (autophagy/beclin-1 reg-
ulator-1) has been defined as a novel regulator of mitophagy in both PINK1/PARKIN-
dependent and -independent systems. Here, we identified the E3 ubiquitin ligase HUWE1 as a
key inducing factor in AMBRA1-mediated mitophagy, a process that takes place indepen-
dently of the main mitophagy receptors. Furthermore, we show that mitophagy function of
AMBRA1 is post-translationally controlled, upon HUWE1 activity, by a positive phosphor-
ylation on its serine 1014. This modification is mediated by the IKKα kinase and induces
structural changes in AMBRA1, thus promoting its interaction with LC3/GABARAP (mATG8)
proteins and its mitophagic activity. Altogether, these results demonstrate that AMBRA1
regulates mitophagy through a novel pathway, in which HUWE1 and IKKα are key factors,
shedding new lights on the regulation of mitochondrial quality control and homoeostasis in
mammalian cells.
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M itophagy is an evolutionary-conserved mechanism thatallows damaged or undesired mitochondria removal byan autophagosome–lysosome pathway1. This high-
quality clearance system is fundamental for preserving cellular
homoeostasis and for critical processes, such as inflammation and
cell death or diseases, including cancer and neurodegeneration2.
The main mitophagy pathway is driven by the stabilization of the
mitochondrial kinase PINK1, resulting in the recruitment of the
E3 ubiquitin ligase PARKIN to damaged mitochondria, and in a
ubiquitylation cascade targeting several outer mitochondrial
membrane (OMM) proteins. Indeed, ubiquitylation events are
fundamental during mitophagy, contributing to the normal
turnover of mitochondrial proteins in basal conditions3, and
promoting the recognition of UBD (ubiquitin binding domain)-
containing proteins, which allow mitochondria selective autop-
hagy4. Optineurin (OPTN) and NDP52 are the the main mito-
phagy receptors, acting as bridges between ubiquitin-tagged
mitochondria and the autophagosome-associated protein,
MAP1LC3/LC3 (microtubule-associated proteins 1A/1B light
chain 3), thus leading to mitochondria engulfment into autop-
hagosomes, upon mitochondrial membrane depolarization5,6.
More recently, PHB2 (Prohibitin-2), an inner mitochondrial
membrane protein, has also been demonstrated to be involved in
selective mitochondria removal, cooperating with PARKIN in
mammals7.
Besides the PINK1/PARKIN system, the OMM proteins NIX/
BNIP3L, Bcl2-L-13 and FUNDC1 are also fundamental to trigger
mitophagy in mammals, by interacting directly with LC3 and
regulating mitochondrial clearance. In particular, (i) NIX/BNIP3L
promotes mitochondria removal during reticulocytes
differentiation8,9; (ii) Bcl2-L-13 is the mammalian homologue of
Atg32, and it stimulates mitochondria fragmentation and there-
fore mitophagy10; and lastly, (iii) FUNDC1 allows mitochondrial
clearance upon hypoxia11. Of note, these mitophagy receptors are
post-translationally modified in order to regulate their interaction
with LC3 during mitophagy12.
We previously demonstrated that the LC3-interacting protein
AMBRA1 plays a role in the selective degradation of ubiquitylated
mitochondria, transducing both canonical PINK1/PARKIN-
dependent and -independent mitophagy13. Here, we describe
HUWE1 as the novel E3 ubiquitin ligase that collaborates with
AMBRA1 to induce mitochondrial clearance, by inducing mito-
fusin 2 (MFN2) degradation. Moreover, since AMBRA1 exhibits
(i) mitochondria localization14, (ii) a LIR (LC3-interacting
region) motif and (iii) the capacity to induce mitophagy13, we
decided to investigate whether AMBRA1 could be defined as a
receptor, and to better characterize this pathway. We thus found
that the activity of the mitophagy receptor AMBRA1 is regulated
by a phosphorylation upstream of its LIR motif, mediated by the
IKKα kinase.
Altogether, these findings highlight AMBRA1, HUWE1 and
IKKα as three novel and crucial proteins for mammalian mito-
phagy regulation, following mitochondrial membrane depolar-
ization in a PINK1/PARKIN-free context.
Results
HUWE1 is required for AMBRA1-mediated mitophagy. Since
we have previously shown that AMBRA1 regulates the dismissal
of ubiquitylated mitochondria in PINK1/PARKIN-independent
mitophagy13, we searched for a novel putative E3 ubiquitin ligase,
which could control mitochondrial protein ubiquitylation in
cooperation with AMBRA1 during the mitophagy process.
To this aim, we performed a SILAC (stable isotope labelling by
amino acids in cell culture)-based mass spectrometry (MS)
analysis in order to detect AMBRA1-interacting proteins, upon
mitophagy stimulation, in a PARKIN-free cellular system. Thus,
we immunoprecipitated Myc-AMBRA1ActA (an AMBRA1 fusion
protein targeted to the external membrane of mitochondria),
which stimulates mitophagy13 in HeLa cells grown in two
different isotope labelling media (light and heavy). The
immunoprecipitated samples of the negative control (light
medium lysate) and the experimental sample (heavy medium
lysate) were mixed and then analysed by MS analysis15.
Interestingly, this screening led us to identify a single E3
HECT-Ubiquitin ligase, HUWE1 (ARF-BP1, MULE, UREB1),
whose role in macroautophagy/mitophagy was yet undisclosed
(Fig. 1a).
In order to confirm these MS results, we performed a co-
immunoprecipitation experiment in HeLa cells expressing a
vector encoding for Myc-AMBRA1ActA. Total lysates were
immunoprecipitated with an anti-Myc antibody or an IgG
control and the immune-complexes were analysed by western
blotting. We found that AMBRA1ActA was able to co-
immunoprecipitate with HUWE1 (Fig. 1b). Since the expression
of AMBRA1ActA induces mitophagy per se13, we decided to
compare the binding between AMBRA1WT and HUWE1 in basal
versus mitophagy conditions. To this end, we over-expressed
HUWE1- and Myc-AMBRA1WT-encoding constructs in HeLa
cells, treated or not with oligomycin and antimycin (O/A) in
order to induce mitophagy. Total lysates were immunoprecipi-
tated using an anti-HUWE1 antibody or IgG control and the
immune-complexes were analysed by western blot. As shown in
Fig. 1c, AMBRA1WT preferentially binds HUWE1 following
mitophagy induction.
Given the evidence that HUWE1 is an AMBRA1-interacting
protein preferentially upon mitophagy stimulation, we then
focussed on a putative role of HUWE1 in mitophagy.
First, since HUWE1 is an E3 ubiquitin ligase mainly found in
the cytoplasm16, we checked whether it was present at the
mitochondria following mitophagy induction. By performing a
mitochondria–cytosol fractionation in HeLa cells expressing
Myc-AMBRA1ActA or an empty vector (PcDNA3), we found
that AMBRA1ActA expression enables HUWE1 localization at the
mitochondria (Fig. 1d). It is noteworthy that HUWE1 translo-
cates to the mitochondria in also AMBRA1WT-expressing cells
upon mitophagy stimulation (Fig. 1e).
Next, in order to assess the effect of HUWE1 genetic silencing
on AMBRA1ActA-induced mitophagy, we checked mitophagy
progression upon downregulation of HUWE1 via small interfer-
ing RNA (siRNA). As shown in Fig. 1f and in Supplementary
Figure 1a, the decrease of mitochondrial markers associated with
AMBRA1ActA expression13, such as COXII and COXIV, is
rescued in HUWE1-interfered cells. To confirm these data, we
performed a confocal microscopy analysis in cells co-expressing
both GFP-ShHUWE1 or GFP-ShCtr together with AMBRA1ActA,
and we measured the mitochondria amount in transfected green
fluorescent protein (GFP)-positive cells. As expected, following
AMBRA1ActA expression with GFP-ShCtr, we observed the
formation of mitochondria aggregates (mito-aggresomes) around
the nuclei, and a decrease in mitochondria staining; by contrast,
GFP-ShHUWE1 transfected cells presented a delay in both mito-
aggresomes formation and mitochondrial clearance (Supplemen-
tary Fig. 1b). In addition, since we had previously demonstrated
that AMBRA1 is able to induce mitophagy in a PINK1-
independent manner13, we analysed AMBRA1–HUWE1 effect
in mitophagy regulation also in mt-mKeima-expressing PINK1
knockout (mt-mKeima-PINK1-KO) HeLa cells5. As shown in
Supplementary Fig. 1c, besides a strong localization of mitochon-
dria into an acidic environment, following Myc-AMBRA1ActA
transfection, we also observed a reduction of acidic mt-mKeima
upon HUWE1 downregulation. These data confirm that HUWE1
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depletion impairs AMBRA1-mediated mitophagy. Finally, we also
confirmed these data with the wild-type AMBRA1, following
mitophagy induction. In fact, we transfected HeLa cells with Myc-
AMBRA1WT in combination or not with siRNA-HUWE1. Then,
we treated cells with O/A (2.5 μM and 0.8 μM, respectively, 4 h).
By western blot analysis, we observed a decrease of mitochondrial
markers, COXII and COXIV, in the mitophagy context (Fig. 1g
and Supplementary Fig. 1c).
In sum, these findings define a central role for the E3 ubiquitin
ligase HUWE1 in controlling AMBRA1-dependent mitophagy.
Upon mitophagy, AMBRA1 acts as a cofactor for HUWE1
activity. Since HUWE1 depletion results in a block of AMBRA1-
mediated mitophagy, we hypothesized that, in the meantime,
mitochondria could be less ubiquitylated in that context.
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To verify this hypothesis, we transfected HeLa cells with Ctr-
siRNA or HUWE1-siRNA in combination with a vector encoding
Myc-AMBRA1ActA. We then performed a subcellular fractiona-
tion and analysed ubiquitylation in the mitochondria lysates,
measuring the amount of total ubiquitin in these extracts,
following AMBRA1ActA transfection. As expected, we observed a
reduction of the total mitochondrial ubiquitylation in HUWE1-
interfered cells during AMBRA1ActA-induced mitophagy when
compared to control cells (Fig. 1h).
We next focalized our attention on MFN2, an OMM pro-
fusion protein, whose ubiquitylation is known to be mediated by
several E3 ubiquitin ligases, including HUWE117, and whose
degradation is known to be crucial for mitophagy induction18.
We thus tested whether HUWE1–MFN2 interaction could be
regulated by AMBRA1, upon mitophagy induction. To this aim,
we transfected HEK293T cells stably expressing Flag-HUWE1
with a vector encoding Myc-AMBRA1ActA. After treatment with
the proteasome inhibitor MG132, we immunoprecipitated cell
lysates with an anti-Flag antibody and observed that the
expression of Myc-AMBRA1ActA strongly favours the interaction
between HUWE1 and MFN2 (Fig. 1i). Accordingly, by an in vitro
ubiquitylation assay, we observed that Myc-AMBRA1ActA
expression in HEK293T-Flag-HUWE1 cell clones strongly
increases MFN2 ubiquitylation compared to control conditions
(Fig. 1j).
Last, we checked for MFN2 degradation in AMBRA1-mediated
mitophagy (18 h following Myc-AMBRA1ActA expression). By
analysing MFN2 protein levels in Myc-AMBRA1ActA transfected
cells, we observed a decrease in this OMM protein. Interestingly,
MFN2 decrease is rescued by downregulating HUWE1 or by
treating cells with MG132 (Fig. 1k and Supplementary Fig. 1d).
These data suggest that MFN2 ubiquitylation is an early event,
following Myc-AMBRA1ActA expression, controlled by HUWE1
and most likely required for AMBRA1-mediated mitophagy.
Altogether, these results indicate that AMBRA1 favours
MFN2–HUWE1 interaction, thus leading to MFN2 ubiquityla-
tion and subsequent degradation, with a final effect on mitophagy
induction. AMBRA1 can be thus considered as a novel cofactor
for HUWE1 ubiquitin ligase activity, underlining a new paradigm
for the regulation of HUWE1.
AMBRA1 is a relevant mitophagy receptor. Next, since
AMBRA1 (i) operates as a cofactor for HUWE1 activity in order
to trigger mitophagy, (ii) displays mitochondrial localization14,
(iii) exhibits a LIR motif on its sequence for LC3B binding, (iv) is
able to regulate PINK1/PARKIN-independent mitophagy and (v)
controls the PINK1/PARKIN-mediated mitophagy13, we inves-
tigated whether AMBRA1 can act as a mitophagy receptor.
To this aim, we checked for AMBRA1-mediated mitophagy
efficiency using the well-known model of stable Penta-KO cells,
unable to perform mitophagy5. Indeed, these cells are deficient for
five mitophagy receptors, i.e., OPTN, NDP52, NBR1, P62 and
TAX1BP1. In these cells, only the expression of NDP52 or OPTN
(or TAX1BP1, in a few cases) is able to rescue the mitophagy
pathway. In fact, the treatment of these cells with mitochondrial
uncouplers does not induce mitophagy (Supplementary Fig. 2a).
Thus, we transfected Penta-KO cells with a vector encoding Myc-
AMBRA1ActA. Western blot analysis, performed on extracts
obtained 24 h after transfection, showed a decrease of mitochon-
drial markers, i.e., COXII, COXIV, and also HSP60 (Supplemen-
tary Fig. 2b), underlining that AMBRA1 expression at the
mitochondria is sufficient per se to induce mitophagy in Penta-
KO cells (Fig. 2a). Furthermore, by performing a confocal
microscopy analysis, we observed that AMBRA1ActA expression
in Penta-KO cells led to mitochondria perinuclear re-localization,
typical of mitophagy induction, followed by a decrease in the
mitochondrial mass (Fig. 2b).
Given the powerful ability of AMBRA1ActA to induce
mitophagy in these cells, we also checked whether wild-type
AMBRA1 could promote mitochondria selective removal. To this
end, we transiently transfected Penta-KO cells with a vector
encoding for Myc-AMBRA1WT and treated cells with O/A for 24
h in order to induce mitophagy. By western blot analysis, we
observed a decrease in the levels of the mitochondrial markers
COXII and COXIV, thus confirming the central role of AMBRA1
in promoting mitophagy in this cell line (Fig. 2c). Of note,
following overexpression of AMBRA1WT, in the absence of any
mitophagy treatments, all mitochondrial markers showed a
marked decrease.
Also in this case, we confirmed the data by performing a
confocal microscopy analysis in which we observed the formation
of mito-aggresomes and then a decrease of mitochondria content
in cells overexpressing AMBRA1WT (Fig. 2d). Finally, in order to
ascertain that the AMBRA1-dependent mitochondrial decrease
was well associated to lysosomal degradation, we treated cells
with the lysosomal inhibitor NH4Cl (Supplementary Fig. 2c).
Indeed, an almost complete rescue of COXIV and COXII levels
by NH4Cl confirmed that a block in lysosomal degradation
restored the total amount of mitochondria within the cells.
Taken together, our findings reveal that AMBRA1 acts as a
relevant mitophagy receptor, capable to induce mitophagy in
NDP52-, OPTN-, TAX1BP1-, NBR1- and P62-deficient cells.
AMBRA1 phosphorylation regulates AMBRA1-dependent
mitophagy. A key process in the induction of selective autop-
hagy is the interaction between mitophagy receptors and Atg8
(autophagy-related protein 8) protein family members19, which
Fig. 1 HUWE1 cooperates in AMBRA1-mediated mitophagy. a Table showing the E3 ubiquitin ligase interacting with AMBRA1 upon mitophagy stimuli in
HeLa PARKIN-free cells. The ratio of heavy labelled peptides to the remaining non-labelled ones (ratio H/L) reflects is indicated. b Representative image of
AMBRA1ActA-HUWE1 co-immunoprecipitation (Co-IP); n= 3. c Representative image of AMBRA1WT-HUWE1 co-immunoprecipitation (Co-IP) upon
mitophagy stimulation (O/A); n= 3. d PcDNA3 or Myc-AMBRA1ActA transfected HeLa cells were subjected to mitochondria–cytosol purification. Samples
were blotted for the indicated antibodies; n= 3. e PcDNA3 or Myc-AMBRA1WT transfected HeLa cells were treated with O/A for 30min and subjected to
mitochondria–cytosol purification; n= 3. f HeLa cells transfected with PcDNA3 or Myc-AMBRA1ActA vectors were transfected with siRNA-Ctr or siRNA-
HUWE1 constructs and then immunoblotted for the indicated proteins; n= 3. g Following O/A treatment, PcDNA3- or Myc-AMBRA1WT-expressing HeLa
cells transfected with siRNA-Ctr or siRNA-HUWE1 were immunoblotted for the indicated antibodies; n= 3. h PcDNA3, Myc-AMBRA1ActA and Myc-
AMBRA1ActA transfected cells interfered for HUWE1 were blotted for the indicated antibodies. The graph shows the total ubiquitin amount in mitochondria
fractionation sample (%); n= 3. i HEK293T stably expressing Flag-HUWE1, transfected with a vector coding for Myc-AMBRA1ActA and treated with
MG132 (10 μM, 8 h) were co-immunoprecipitated and immunoblotted for the indicated proteins; n= 3. j In vitro ubiquitylation assay of cells in i. Protein
samples were resolved by SDS–PAGE and immunoblotted for Myc, MFN2 and HUWE1; n= 2. k HeLa cells transfected with Myc-AMBRA1ActA (18 h) and
interfered for HUWE1 (siRNA-HUWE1) were analysed by western blot; n= 3. The quantification results are the mean of three independent experiments
(±S.D.). *P < 0.05; **P < 0.01. Statistical analysis was performed using one-way ANOVA (f, g, k) and Student's t-test (d, e, h). Mr(K) = relative molecular
mass expressed in kilodalton
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Fig. 2 AMBRA1 expression rescues mitophagy induction in Penta-KO cells. a Penta-KO cells transfected with a vector encoding for Myc-AMBRA1ActA or
an empty vector (PcDNA3) for 24 h were immunoblotted for the indicated antibodies; n= 3. b Myc-AMBRA1ActA (red) or Mito-DsRED (red) transfected
Penta-KO cells were fixed after 24 h. Scale bar, 10 μm. The graph shows the mito content (%) in single transfected cells (±S.D.); n= 4. Mito-DsRED= 12
individual fields; Myc-AMBRA1ActA= 12 individual fields. c Penta-KO cells were transfected with vectors encoding Myc-AMBRA1WT or PcDNA3 and
treated with O/A (10 μM and 4 μM, respectively) for 24 h. Mitochondrial markers levels, COXII and COXIV, were evaluated by western blot; n= 3. d Cells
transfected with Mito-DsRED or with Myc-AMBRA1WT were immunostained with an anti-Myc (green) and anti-TOM20 (red) antibodies. Scale bar, 10 μm;
n= 3. Mito-DsRED= 9 individual fields; Myc-AMBRA1WT= 9 individual fields; Myc-AMBRA1WT+O/A= 9 individual fields. *P < 0.05; **P < 0.01; ***P <
0.001; ****P < 0.0001. The quantification results are the mean of three independent experiments (±S.D.) if not otherwise stated. Statistical analysis was
performed using Student’s t-test (a, b) or one-way ANOVA (c, d). Mr(K) = relative molecular mass expressed in kilodalton
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are LC3 and GABARAP proteins in mammals (mATG8). Since
the phosphorylation status of a serine residue (Ser) flanking the
LIR motifs of known mitophagy receptors, such as FUNDC111,
BNIP320, NIX/BNIP3L9,21, Bcl2-L-1310 and OPTN22, controls
their binding with LC3, we investigated whether AMBRA1 could
be post-translationally modified in a serine site in proximity of its
LIR motif13.
First, through an in silico analysis of the AMBRA1 sequence,
we identified serine 1014 (S1014) as a putative phosphorylation
site close to the AMBRA1-LIR motif (Fig. 3a). Second, in order to
demonstrate whether the phosphorylation on S1014 was able to
influence AMBRA1–LC3B interaction in cells, we generated two
AMBRA1 mutants, a phospho-dead mutant (AMBRA1S1014A)
and a phospho-mimetic mutant (AMBRA1S1014D). By
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performing co-immunoprecipitation experiments, we analysed
AMBRA1–LC3B interaction in basal conditions and upon
mitophagy stimulation (O/A treatment), obtained by overexpres-
sing Myc-AMBRA1WT and AMBRA1S1014A or AMBRA1S1014D
in HeLa cells. First, we confirmed that AMBRA1 interacts mostly
with LC3B following mitophagy stimuli13. Moreover, we observed
that alanine substitution at residue 1014 reduced the binding
between AMBRA1 and LC3B, following O/A treatment (Fig. 3b).
By contrast, the AMBRA1S1014D enhanced the ability of
AMBRA1 to interact with LC3B during mitophagy.
These results highlight that the phosphorylation status of
AMBRA1 on S1014 influences the interaction between AMBRA1
and LC3B during mitophagy.
Next, in order to ascertain whether S1014 is relevant in
AMBRA1-induced mitophagy, we performed functional experi-
ments to evaluate the mitophagy activity of AMBRA1WT
compared with its mutants on S1014. To this aim, we transfected
HeLa cells with the empty vector PcDNA3 as a control, and
vectors encoding Myc-AMBRA1WT or Myc-AMBRA1S1014A or
Myc-AMBRA1S1014D and checked, by western blot analysis, the
levels of mitochondrial proteins COXII and COXIV.
Interestingly, upon mitophagy stimulation (by O/A treatment),
HeLa cells transfected with AMBRA1WT showed a decrease in
COXII and COXIV levels, while cells expressing the
AMBRA1S1014A mutant showed a lower decrease in mitochon-
drial marker levels compared with AMBRA1WT or
AMBRA1S1014D (Fig. 3c). Of note, the AMBRA1S1014D mutant
significantly increased the mitophagy ability of AMBRA1 when
compared with the AMBRA1WT form (Fig. 3c). Also, we analysed
mitochondrial clearance by confocal immunofluorescence, look-
ing at TOM20 levels, in HeLa cells expressing GFP, Myc-
AMBRA1WT, Myc-AMBRA1S1014A or Myc-AMBRA1S1014D.
Indeed, we observed that the phospho-mimicking mutation
(Myc-AMBRA1S1014D) induced mito-aggresome formation and a
clear decrease of mitochondria amount to a larger extent than
AMBRA1WT (Fig. 3d). Moreover, we also validated these data
using HeLa cells expressing the mito-mKeima vector5. In analogy
with our biochemistry and immunofluorescence analysis, mito-
chondria of Myc-AMBRA1S1014D-expressing cells were predomi-
nantly found in an acidic environment, suggesting ongoing
mitophagy. By contrast, Myc-AMBRA1S1014A transfected cells, in
which we previously observed a delay in mitophagy, were mostly
present in a neutral environment (Supplementary Fig. 3a).
Since we demonstrated that phosphorylation of AMBRA1 on
S1014 was a crucial event in order to regulate AMBRA1-mediated
mitophagy, we next decided to check whether endogenous
AMBRA1 was also subjected to such modification. We thus
generated, through rabbit immunization, an anti-AMBRA1
serum that specifically recognized the phosphorylation at S1014
(anti-Phospho(P)-S1014-AMBRA1 serum). We tested its effi-
ciency by comparing the level of phospho-S1014 in basal versus
mitophagy (carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP), O/A) or autophagy conditions (Earle’s
balanced salt solution (EBSS)). As shown in the graph (Fig. 3e),
we observed a significant increase in the phosphorylation signal
following FCCP and O/A treatments, indicating that phosphor-
ylation of AMBRA1 on S1014 was occurring specifically upon
mitochondrial membrane depolarization during mitophagy
induction. In addition, we proved that the anti-P-S1014-
AMBRA1 antibody was able to specifically recognize AMBRA1
by analysing endogenous AMBRA1 levels in siRNA-Ctr- or
AMBRA1-interfered cells by siRNA-AMBRA1 (Supplementary
Fig. 3b). We also confirmed that this antibody was able to better
recognize over-expressed AMBRA1WT if compared to the
phospho-dead AMBRA1S1014A form (Supplementary Fig. 3c).
Taken together, these data indicate that the phosphorylation of
S1014 on AMBRA1 regulates the AMBRA1–LC3B interaction
and its mitophagy activity. We have also generated an anti-P-
S1014-AMBRA1 antibody that recognized this AMBRA1
dynamic post-translational modification.
S1014-AMBRA1 phosphorylation increases the binding with
mATG8s. In order to characterize the binding affinity between
AMBRA1-LIR and LC3/GABARAP proteins, and to confirm that
the phosphorylation of S1014 in AMBRA1 increases this affinity,
we performed isothermal titration calorimetry (ITC) experiments
in which synthetic peptides spanning the AMBRA1-LIR at var-
ious phosphorylation states (P0: steady state and P1: phosphor-
ylation state) were titrated into all six mATG8 proteins, including
LC3A, LC3B, LC3C, GABARAP, GABARAP-L1 and GABARAP-
L2 (Supplementary Fig. 4a-c, and Supplementary Note 1). The
ITC experiments showed that the unmodified AMBRA1-LIR (P0)
binds to LC3B with very low affinity (Fig. 4a left panel). KD values
for this interaction were in the range of >100 μM, a value ~100
higher than the canonical p62-LIR, and comparable to the
unphosphorylated NIX- and OPTN-LIR affinities13,22,23. How-
ever, LC3B affinity to AMBRA1-LIR unambiguously increased
upon S1014 phosphorylation, resulting in KD of 53 μM (Fig. 4a,
right panel). Moreover, the nuclear magnetic resonance (NMR)
titration experiments indicated a very similar effect of AMBRA1-
LIR phosphorylation on its affinity to LC3B (Fig. 4b, c). Inter-
estingly, although ITC experiments showed that the unmodified
AMBRA1-LIR (P0) bound all 6 mATG8 proteins with low affinity
(Supplementary Fig, 4a, upper plots), it exhibited some preference
to GABARAP-subfamily proteins. In fact, strongest interaction
appeared to the GABARAP protein, with KD of ~40 μM, while for
the LC3 proteins and for GABARAP-L2 KD values could be only
estimated. Of note, the binding enthalpy for all mATG8 proteins
is small, defining the entropy as the main driving force of the
interactions. However, both phosphorylation of S1014 (P1, Sup-
plementary Fig. 4b) and introduction of phospho-mimicking
aspartate to this position (PM, Supplementary Fig. 4c) increased
affinity of AMBRA1-LIR interaction with mATG8 analogues (KD
values decreased ~2–5 times). In particular, phosphorylation of
Fig. 3 S1014-AMBRA1 phosphorylation is crucial for AMBRA1–LC3 interaction. a Sequence alignment of AMBRA1–S1014 site, flanking its LIR motif, in
comparison with the S1014A (phospho-dead) and S1014D (phospho-mimetic) generated mutants. b HeLa transfected with Myc-AMBRA1WT, Myc-
AMBRA1S1014A or Myc-AMBRA1S1014D were treated or not with O/A (2.5 μM, 0.8 μM, 1 h) and subjected to co-immunoprecipitation (Co-IP). The graph
shows the ratio between Co-IP LC3II/IP-AMBRA1 upon mitophagy induction; n= 3. Statistical analysis was performed using Student’s t-test versus the
wild-type form of AMBRA1. c PcDNA3, Myc-AMBRA1WT, Myc-AMBRA1S1014A or Myc-AMBRA1S1014D transfected HeLa cells were treated with O/A (2.5
μM, 0.8 μM, 4 h) and blotted for COXII, COXIV, Myc and ACTIN; n= 3. d Cells transfected with a vector encoding for GFP, Myc-AMBRA1WT, or Myc-
AMBRA1S1014A or Myc-AMBRA1S1014D were treated with O/A as indicated above and stained with anti-Myc and anti-TOM20 (red staining) antibodies.
Scale bar, 10 μm; n= 3. Myc-AMBRA1WT= 9 individual fields; Myc-AMBRA1S1014A= 9 individual fields; Myc-AMBRA1S1014D= 9 individual fields.
e Untransfected HeLa cells were treated with mitophagy inducers, such as FCCP (10 μM) and O/A (2.5 μM and 0.8 μM) or with the starvation medium
EBSS in order to induce autophagy for 4 h; n= 3. Data represent the mean of three different samples (±S.D.) and are representative of experimental
triplicate. *P < 0.05; **P < 0.01; ***P < 0.001. Statistical analysis was performed using Student’s t-test (b) or one-way ANOVA (c, d, e). Mr(K) = relative
molecular mass expressed in kilodalton
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Fig. 4 S1014-AMBRA1 phosphorylation allows AMBRA1–LC3B binding. a ITC titrations of unmodified AMBRA1-LIR peptide (P0) compared with those of
S1014-phosphorylated AMBRA1-LIR peptide (P1) into LC3B protein. The measurements were performed at 35 °C. Measured/estimated KD values are
indicated for each interaction. b Representative sections of HSQC spectra for 15N-labelled LC3B upon titration with P0 and P1. Both plots show fingerprint
regions of the LC3B spectra (around HN resonance of K51). Molar ratios of protein/peptide are rainbow coloured (1:0, 1:0.125, 1:0.25, 1:0.5, 1:1, 1:2, 1:4 and
1:8; from red to violet) for each titration step. Arrows indicate the CSP for K51 and V58 HN backbone resonances. c KD values calculated for the LC3B
residue I34 upon titration with P0 and P1. Original CSP values are shown as black squares and the resulting fit is given as a red line in each plot. The original
HSQC areas around I34 HN resonance are shown as a box under fitted curves. d CSP values (Δδ) at the last titration stages for LC3B protein are plotted
against residues numbers. The orange dashed line indicates the standard deviations (σ) over all residues within each dataset, and the red dashed line
indicates double σ values. The CSP values mapped on the LC3B protein structure (ribbon diagrams, PDB ID 1UGM) are shown in the upper right corner.
Residues with small (Δδ < σ), intermediate (σ <Δδ < 2σ) or strong (2σ <Δδ) CSPs are marked in grey, yellow and red, respectively. e The root mean square
fluctuation (RMSF) per residue of AMBRA1 decreases after S1014 phosphorylation (blue, green lines) compared to wt (magenta, red lines) and control P62
(black line) and is persistent with CHARMM22* (black, green and magenta lines) and CHARMM27 (blue and red lines) force fields. Shaded area
corresponds to 1 σ. f Superimposition of highly populated (>20%) electrostatic interactions (red bars, thickness indicates occurrence) over the LC3B/
AMBRA1-LIR structure. Interactions identified between residues of S1014-phosphorylated AMBRA1-LIR (right panel) and LC3B are identified by spheres
and reproduced on the wt (left panel). Similar patterns were seen for simulations using CHARMM22* (shown here) and CHARMM27 force fields
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S1014 (P1, Supplementary Fig. 4b, low panel) enhanced the
binding with the GABARAP protein and therefore the KD shifted
down to 21 μM, as determined by ITC. Based on chemical shift
perturbations (CSP), we precisely calculated KD values for LC3B
interaction with unphosphorylated (P0) and phosphorylated (P1)
AMBRA1-LIR peptides. We also mapped the CSP on the LC3B
sequence and three-dimensional structure (Fig. 4d). Comparison
of the mapped AMBRA1-LIR CSP pattern to previously pub-
lished mappings indicated that the AMBRA1-LIR interacts with
LC3B in a typical LIR mode and phosphorylation on S1014 close
to the LIR motif enhances these interactions.
In order to understand the structural impact of S1014-
AMBRA1 phosphorylation on the LC3B binding, we performed
multi-replicate molecular dynamics (MD) simulations, evaluating
conformations of the steady-state structure of AMBRA1 when
compared to the phosphorylated structure. In this case, we used
the P62-LIR/LC3B experimental structure as a template for
modelling. As shown in the plot of Fig. 4e, in analogy to the
canonical complex P62-LC3B, the root mean square fluctuation
(RMSF), an index of structural flexibility of AMBRA1–LC3B
interaction, showed a decrease in flexibility, upon phosphoryla-
tion of S1014 (blue and green lines; Fig. 4e). Interestingly, the
phospho-variant was characterized by a flexibility profile
comparable to the canonical p62-LIR (black line; Fig. 4e),
suggesting that this post-translational modification is needed to
compensate for the lower binding affinity of the unphosphory-
lated AMBRA1-LIR, with respect to other known LIR domains.
Moreover, we observed that the stabilization induced by the
phospho-S1014 was likely due to an increase in electrostatic
interactions promoted by this residue (locally and long-range)
(Fig. 4f).
Taken together, these results give a proof of concept that
phosphorylation of S1014 is fundamental to stabilize the
conformation of AMBRA1-LIR in the binding pocket of LC3B,
thus promoting its interaction with LC3B (and most likely with
all mATG8 proteins) and its mitophagy activity.
IKKα kinase phosphorylates AMBRA1 at S1014 during mito-
phagy. In order to define which kinase could regulate AMBRA1
phosphorylation at S1014 during mitophagy, we performed a
bioinformatic analysis by using the Group-based Prediction
System (GPS) software24. One of the candidates with the highest
score was the IKKα kinase (also termed CHUK), a
serine–threonine kinase belonging to the IKK family that includes
IKKα, IKKβ, IKKγ, IKKε and TBK1 proteins25. The predicted
IKKα consensus motif26 was localized upstream of the LIR motif
of AMBRA1 (Fig. 5a), suggesting a potential role of IKKα in
AMBRA1-mediated mitophagy. To prove this biochemically, we
first checked for a putative binding between AMBRA1 and the
IKKα kinase. To this end, we over-expressed, in HeLa cells, the
kinase-dead mutant of IKKα (HA-IKKαK44M)27 in order to avoid
a kiss and run action between the wild-type kinase and AMBRA1,
and then we immunoprecipitated the IKKα mutant with an anti-
HA antibody and, finally, we checked for AMBRA1–IKKα com-
plex by western blot analysis. As shown in Fig. 5b, we found a
binding between the two proteins, suggesting that AMBRA1
could be a substrate for IKKα. To test this hypothesis, we decided
to investigate the effect of the well-known IKKα-specific and
irreversible inhibitor BAY-117082 on AMBRA1 phosphorylation
at S1014 during mitophagy. As shown in Fig. 5c, we observed a
clear reduction of AMBRA1 phosphorylation on S1014, when
cells were treated with BAY-117082 compared to cells treated
with the vehicle (dimethyl sulfoxide). These results suggested that
the IKKα kinase was responsible for the phosphorylation on
S1014 of AMBRA1 following mitophagy induction. To strengthen
these data, we decided to test the effect of the kinase-dead form of
IKKα (IKKαK44M), which acts as a dominant negative mutant27,
on AMBRA1 phosphorylation at S1014. To this end, we over-
expressed vectors encoding Flag-IKKαWT or HA-IKKαK44M in
HeLa cells, and we induced mitophagy by using O/A. As shown
in Fig. 5d, the expression of the kinase-dead version of IKKα was
sufficient to abolish AMBRA1 phosphorylation at S1014 follow-
ing O/A treatment, similarly to BAY-117082 (see Fig. 5c). Con-
sistent with these results, we validated the IKKα-mediated
phosphorylation on AMBRA1 at S1014 by an in vitro kinase
assay, comparing the activity of IKKαWT to its kinase-dead
mutant. To this end, we transfected HeLa cells with a vector
encoding Myc-AMBRA1WT, Flag-IKKαWT or HA-IKKαK44M and
immunoprecipitated individually these three proteins from the
mitochondrial fraction. Then, we combined the immunopreci-
pitated kinases (IP-IKKαWT or IP-IKKαK44M) with the immu-
noprecipitated substrate (IP-AMBRA1). The western blot analysis
showed that the phosphorylation signal at AMBRA1–S1014 was
present only in the IP-IKKα fraction (Fig. 5e). Subsequently, we
also performed an in vitro kinase assay with human recombinant
AMBRA1 as a substrate in order to formally prove a direct effect
of the IKKα kinase on its novel substrate. As shown in Fig. 5f, the
phosphorylated form of AMBRA1 at S1014 was detected when
mixed with the IP-IKKα, but was not appreciated in the kinase-
dead IP-IKKαK44M sample. Despite TBK1 and IKKα kinases
shared a similar structure, we did not observe any effects of the
TBK1 kinase on S1014 phosphorylation of AMBRA1 (Supple-
mentary Fig. 5a).
These results prove that IKKα is the kinase responsible for
AMBRA1 phosphorylation at S1014 upon mitophagy induction,
and thus it represents a novel upstream factor accountable for
mitophagy activation.
IKKα inhibition impairs AMBRA1-mediated mitophagy. In
order to verify whether the abolishment of IKKα kinase activity
could inhibit AMBRA1-mediated mitophagy, we tested the effect
of IKKα inhibition on AMBRA1-mediated mitophagy. To this
end, we checked for mitophagy induction in HeLa cells over-
expressing AMBRA1ActA, and treated or not with the IKKα
inhibitor (BAY-117082) by detecting COXII and COXIV levels by
western blot analysis. We observed that BAY-117082 treatment
was able to rescue mitochondrial clearance following
AMBRA1ActA overexpression (Fig. 5g and Supplementary
Fig. 5b).
Of the highest importance, the IKKα inhibitor also impacted
AMBRA1-mediated mitophagy in Myc-AMBRA1WT transiently
transfected HeLa cells, in which we induced mitophagy by O/A.
As shown in Fig. 5h and Supplementary Figure 5c, by analysing
the mitochondrial clearance by western blotting, we also observed
in this case a rescue of the mitochondrial markers COXII and
COXIV upon BAY-117082 treatment.
To validate these data, we co-transfected HeLa cells with a
vector encoding Myc-AMBRA1ActA in combination with HA-
IKKαK44M kinase-dead mutant. Again, by blocking IKKα activity,
by using the dominant negative form of the kinase, we induced
AMBRA1ActA-mediated mitophagy inhibition (Fig. 5i and
Supplementary Fig. 5d). As expected, AMBRA1WT-induced
mitophagy was also reduced in HA-IKKαK44M transfected cells,
confirming that inhibition of IKKα also impaired AMBRA1WT-
mediated mitophagy (Fig. 5j and Supplementary Fig. 5e). More-
over, as a control, we checked whether the nuclear factor (NF)-κB
pathway was involved in this regulation by looking at p65 nuclear
translocation upon mitophagy stimulation. As shown in Supple-
mentary Figure 5f, no evident p65 translocation to the nucleus
was observed upon O/A treatment compared to tumour necrosis
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05722-3 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3755 | DOI: 10.1038/s41467-018-05722-3 | www.nature.com/naturecommunications 9
factorα treatment, indicating that this inflammation pathway was
not activated during mitophagy.
Altogether, these results point to IKKα as an essential factor in
AMBRA1-mediated mitophagy, regulating AMBRA1 phosphor-
ylation at S1014, and highlight a novel and alternative role (rather
than in inflammation) of IKKα in mitophagy.
HUWE1 controls the S1014 phosphorylation of AMBRA1. In
analogy with other mitophagy receptors, the phosphorylation of
AMBRA1 at the S1014 site, flanking its LIR motif, is a crucial
event for the engulfment of ubiquitin-tagged mitochondria into
autophagosomes. Since we demonstrated that HUWE1 down-
regulation results in a block of AMBRA1-mediated mitophagy,
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we hypothesized that HUWE1 activity could influence AMBRA1
phosphorylation at S1014 upon mitophagy induction. Thus, we
transfected HeLa cells with a siRNA-Ctr or siRNA-HUWE1 or
with a vector encoding HUWE1, and then treated cells with O/A
(2.5 μM, 0.8 μM, 1 h).
Interestingly, we observed that the downregulation of HUWE1
induced a significant reduction in AMBRA1–S1014 phosphoryla-
tion upon mitophagy induction. By contrast, HUWE1 over-
expression resulted in increased phosphorylation of AMBRA1 at
the same site (Fig. 6a). In analogy with this result, we observed
that HUWE1 depletion produces a reduction in AMBRA1–LC3B
binding upon mitophagy stimulation (Fig. 6b).
Taken together, these findings clearly define an epistatic role of
HUWE1 in IKKα- and AMBRA1-mediated mitophagy.
AMBRA1 regulates mitochondrial clearance during ischaemia.
Following the evidence on AMBRA1-mediated mitophagy in relay
with HUWE1 and IKKα, we checked the physiopathological rele-
vance of this functional interplay in models of ischaemia. Indeed,
there is general consensus that mitophagy can be triggered in similar
conditions as it happens via receptors. For instance, NIX/BNIP3L
mediates mitochondrial removal during cerebral28 and cardiac29
ischaemia/reperfusion (I/R) injury; also, FUNDC1 is a well-known
regulator of mitophagy under hypoxia11, and its implications in
ischaemia have been recently elucidated30,31. Of note, the intrami-
tochondrial protein ATPIF1, during ischaemia-preconditioning
context, has been reported to regulate selective degradation of
potentially toxic mitochondria (i.e., those generating high doses of
free radicals) by collapsing their membrane potential (ΔΨm)32,33.
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Fig. 6 HUWE1 is crucial for AMBRA1–S1014 phosphorylation. a HeLa cells were transfected with an empty vector (PcDNA3) in combination with a siRNA-
Ctr or a siRNA-HUWE1 or a plasmid encoding for HUWE1. Cells were treated with O/A (2.5 μM, 0.8 μM, 1 h) and total lysates were blotted for the
indicated antibodies; n= 3. b HeLa cells were transfected with siRNA-Ctr or siRNa-HUWE1 and treated with O/A (2.5 μM, 0.8 μM, 1 h). Mitochondrial
fractions were immunoprecipitated using anti-AMBRA1 antibody; n= 3. Data represent the mean of three different samples (±S.D.) and are representative
of experimental triplicate. *P < 0.05. Statistical analysis was performed using one-way anOVA (a) or Student’s t-test (b). Mr(K) = relative molecular mass
expressed in kilodalton
Fig. 5 IKKα controls AMBRA1 phosphorylation at S1014 during mitophagy. a Sequence alignment of the consensus sequence of IKKα-phosphorylation on
IκBα, TAX1BP1 and AMBRA1. b HA-IKKαK44M transfected HeLa cells were subjected to Co-IP and blotted for the indicated antibodies; n= 3.
c Untransfected HeLa cells were treated with O/A (2.5 μM, 0.8 μM, 1 h) and with the IKKα irreversible inhibitor BAY-117082 (2 μM, 1 h); n= 3.
d Representative image of HeLa cells transfected with PcDNA3, Flag-IKKαWT or the kinase-dead HA-IKKαK44M, treated with O/A and blotted for the
indicated antibodies; n= 3. e In vitro kinase assay of immunoprecipitated-Flag-IKKαWT- or HA-IKKαK44M-expressing HeLa cells in which the substrate
(Myc-AMBRA1WT) was transcribed/translated in vitro. Samples were immunoblotted for the indicated proteins; n= 2. f In vitro kinase assay in which the
immunoprecipitated fraction of IKKαWT or IKKαK44M were mixed to recombinant produced AMBRA1; n= 2. g HeLa cells transfected with Myc-
AMBRA1ActA or PcDNA3 (24 h) and treated with BAY-117082 inhibitor were blotted for the indicated antibodies; n= 3. h HeLa cells transfected with Myc-
AMBRA1WT or PcDNA3 and treated with O/A (2.5 μM, 0.8 μM, 5 h) and BAY-117082 inhibitor (2 μM, 5 h) were immunoblotted for the indicated proteins;
n= 3. i HeLa cells transfected with PcDNA3 or HA-IKKαK44M constructs in combination with Myc-AMBRA1ActA were analysed by western blot for the
indicated antibodies; n= 3. j PcDNA3+Myc-AMBRA1WT or Myc-AMBRA1WT+HA-IKKαK44M co-transfected HeLa cells treated with O/A were subjected
to immunoblotting for COXII, COXIV, HA, Myc and ACTIN antibodies; n= 3. Data represent the mean of three different samples (±S.D.) and are
representative of experimental triplicate. *P < 0.05. Statistical analysis was performed using one-way ANOVA (c, g, h, I, j). Mr(K) = relative molecular
mass expressed in kilodalton
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Ischaemia and its prodromal phases are characterized by
detrimental oxidative stress, which we showed to be counteracted
by AMBRA1-induced mitophagy34; this evidence prompted us to
investigate whether AMBRA1 itself could drive mitophagy during
I/R injury.
We thus tested the degree of AMBRA1 phosphorylation in SH-
SY5Y cells exposed to an in vitro model of ischaemia mimicked
by alternative time periods of oxygen-glucose deprivation/re-
oxygenation (OGD/RX)33. Total lysates were then subjected to
western blot analysis of P-S1014-AMBRA1, recording that
AMBRA1 is neatly phosphorylated between 30 min and 1 h of
OGD/RX treatment (Fig. 7a). Nevertheless, the role of endogen-
ous AMBRA1 in this physiopathological activation of mitophagy
was further corroborated by downregulating AMBRA1 in SH-
SY5Y cells exposed to the same OGD/RX protocols. In Fig. 7b,
the decrease of COXII is utterly rescued when AMBRA1 is
removed. Subsequently, we checked whether HUWE1 and IKKα
also actively took part to AMBRA1-mediated mitophagy upon
OGD/RX. In Myc-AMBRA1WT-expressing SH-SY5Y cells,
HUWE1 expression was repressed via siRNA; this primed a
significant rescue of COXII during OGD/RX (Fig. 7c). In another
experiment, we also abrogated IKKα activity by overexpressing
the dominant negative kinase IKKαK44M in SH-SY5Y cells
transfected with Myc-AMBRA1WT. Indeed, 3 h of exposure to
OGD/RX impaired the clearance of mitochondria (Fig. 7d). In
sum, these data lead us to conclude that AMBRA1, together with
HUWE1 and IKKα, may well represent a novel regulator of
ischaemia-induced mitophagy, thus highlighting the
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physiopathological relevance of this pathway in mitochondria
quality control.
Discussion
In the present study, we demonstrated that the mitophagy
receptor AMBRA1 acts at two critical steps during mitochondrial
membrane depolarization-induced mitophagy. First, we identified
the E3 ubiquitin ligase HUWE1 as an important co-operator of
AMBRA1 in order to induce mitophagy, following mitochondrial
membrane depolarization. In particular, we demonstrated that
AMBRA1ActA strongly favours the interaction between HUWE1
and MFN2, thus acting as a cofactor for HUWE1 E3 ubiquitin
ligase activity, and leading subsequently to MFN2 ubiquitylation
and then to its degradation. The data highlight a novel important
paradigm for HUWE1 E3 ubiquitin ligase activity regulation and
open a wide range of studies to understand whether AMBRA1
may control HUWE1 activity in other contexts. Of note, HUWE1
depletion abolishes both MFN2 degradation and AMBRA1-
mediated mitophagy in HeLa cells. Also, it has been established
that MFN2 degradation is an important event for mitophagy
induction35. In line with this evidence, we showed that MFN2 is
degraded in the early steps of AMBRA1-mediated mitophagy (18
h post transfection of Myc-AMBRA1ActA). Moreover, HUWE1
depletion induces a clear reduction of total mitochondria ubi-
quitylation following AMBRA1ActA expression. Since we found
that MFN2 degradation correlates with AMBRA1-mediated
mitophagy induction, it will be necessary to better understand
in the future whether or not this event is a critical step for
AMBRA1-mediated mitophagy. Also, although MNF2 is a
favourite substrate of HUWE1, it will be important to investigate
whether HUWE1 could ubiquitylate other mitochondrial sub-
strates in order to control mitophagy induction.
We recently demonstrated that AMBRA1 is a BH3 (BCL2-
homology domain 3)-like protein, containing a BH3 domain
necessary for its interaction with BCL2 family proteins36,37.
Interestingly, HUWE1 has been defined as a unique BH3-
containing E3 ubiquitin ligase38; it would be interesting to
characterize the binding between AMBRA1 and HUWE1 by
checking, in particular, whether a BH3 mechanism is involved in
this context. Of note, both HUWE1 and AMBRA1 can interact
with the anti-apoptotic factor MCL1 (induced myeloid leukaemia
cell differentiation protein Mcl-1)36,38. In this scenario, it could
also be interesting to define the relationship among
AMBRA1–HUWE1-dependent mitophagy, mitochondrial
dynamics and apoptosis.
The HUWE1–AMBRA1 axis in mitophagy defines a new
pathway for damaged mitochondrial removal related to a novel
E3 ligase, yet unwound in this field, but since AMBRA1 and
HUWE1 are two large multi-domain proteins, they may coop-
erate in several processes, such as cancer, apoptosis and cell
proliferation. In fact, HUWE1 has been described as a tumour
suppressor gene controlling the proto-oncogene c-Myc regula-
tion. HUWE1 participates to c-Myc degradation, leading to a
reduction in tumour diffusion39. It is opportune to underline that
AMBRA1 also controls c-Myc expression, cooperating in the
PP2A-mediated dephosphorylation of c-Myc40. It could thus be
interesting to analyse the correlation between AMBRA1–HUWE1
and c-Myc regulation upon mitophagy stimulation. As previously
demonstrated, mitochondria are fundamental in cellular homo-
eostasis and the HUWE1–AMBRA1 axis can represent a focal
point of interconnection between healthy and tumour cells.
In addition, it is noteworthy that MFN2 degradation is also
mediated by PARKIN activity41. Since we demonstrated that
AMBRA1-dependent mitophagy is not controlled by the PINK1/
PARKIN pathway, we propose here an alternative system that
regulates mitophagy. The removal and proteolysis of OMM
proteins appears to be necessary for mitophagy42. Since the
PINK1/PARKIN pathway is mutated in one of the most diffuse
neurodegenerative disturb, Parkinson’s Disease43,44,
AMBRA1–HUWE1-dependent mitophagy could offer a novel
target therapy to counteract this disease as it may preserve cellular
vitality. The mitophagy programme is a highly intricate system
comprising different characters. In fact, PINK1-related mito-
phagy receptors present UBDs in their sequences that allow the
interaction with Ser65-phosphoUb-containing mitochondria5,45.
By contrast, mitochondrial proteins, such as NIX, FUNDC1 and
Bcl2-L-13, lacking an UBD, can anyway promote mitophagy of
ubiquitylated mitochondria. In our current work, we added a
piece to this heterogeneous puzzle, describing AMBRA1 as a new
UBD-free mitophagy receptor, which acts following mitochon-
drial membrane depolarization. Indeed, we revealed that the
expression of AMBRA1 is sufficient to restore mitochondrial
clearance in cells depleted for PINK1/PARKIN-related mitophagy
receptors, such as NDP52, OPTN, TAX1BP1, P62 and NBR1. In
analogy with mitophagy receptors Bcl2-L-13, FUNDC1 and NIX/
BNIP3L, we demonstrated that AMBRA1 is also able to stimulate
mitochondrial clearance in the absence of any PINK1 phospho-
ubiquitin signals. Indeed, we previously proved that AMBRA1
was able to induce mitophagy in PINK1−/− MEFs cells13.
Moreover, we have proved that AMBRA1-mediated mitophagy
activity is tightly dependent on its phosphorylation state. In
particular, following mitophagy induction, the phosphorylation
on S1014 increases the AMBRA1–LC3B binding thus promoting
an enhancement in AMBRA1-mediated mitophagy. Moreover,
we have revealed that the HUWE1 ubiquitylation signal is fun-
damental not only in tagging mitochondria for mitophagy, but
also in activating AMBRA1 for mitophagy. In fact, we observed
that downregulation of HUWE1 results in a reduction of
AMBRA1-activated phosphorylation state, necessary for its
interaction with the autophagosome marker LC3B. We can
speculate that a fine dual relationship occurs between AMBRA1
and HUWE1: the former is necessary for HUWE1 recruitment to
the mitochondria; the latter, once at the mitochondria, ubiqui-
tylates OMM protein(s), thus inducing mitophagy and producing
a signal for AMBRA1–S1014 phosphorylation, flanking its LIR
motif. This event causes in turn a structural rearrangement
necessary to make the AMBRA1-LIR motif more accessible to
LC3B. In particular, we detected that the negative charge on
S1014 of AMBRA1 produces an increase in electrostatic inter-
actions in the proximity of the tryptophan site (W1020) on the
AMBRA1-LIR motif. As shown in Supplementary Fig. 4, the
importance of electrostatic interactions involving side chains of
mATG8 proteins is confirmed by the NMR titration data. By
performing ITC and NMR experiments, we observed that the
phosphorylation on S1014 is important to increase the affinity
between AMBRA1-LIR and mATG8 proteins (Supplementary
Fig. 4) and this result led us to identify GABARAP proteins as
more specific interacting proteins of AMBRA1. Of note, the
S1014 site is not directly located prior to the core LIR aromatic
residue W1020 of AMBRA1. Therefore, the increase of
AMBRA1–mATG8 binding by S1014 phosphorylation is a quite
unexpected event. For example, the OPTN phosphorylation on
S170, flanking its LIR motif, shows a small increase in affinity to
LC3B24. Based on this, we cannot exclude that other factors (such
as additional residues or structural elements in AMBRA1, or
AMBRA1 additional post-translational modifications) could also
affect the interactions between full-length AMBRA1 and mATG8
proteins. Moreover, since GABARAPs seem to be more involved
in the PINK1/PARKIN-dependent mitophagy pathway than
LC3s46, it will be very interesting to investigate, in the future,
whether AMBRA1 requires a preferentially binding to
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GABARAPs or to LC3s in mitophagy, depending on a particular
context (PINK1/PARKIN dependent or independent) or on other
processes (i.e., macroautophagy or different selective forms of
autophagy).
Our results clearly define the importance of post-translational
modifications on the phosphorylated site, in proximity of the
identified LIR motif of AMBRA1. Several reports demonstrated
the central role of kinase-mediated phosphorylation in cargo
receptor-mediated autophagy11,47. We here demonstrated a novel
role of IKKα, independently of its role in NF-κB pathway in
mitophagy. Interestingly, Criollo et al.48 proved that the IKK
complex was able to promote macroautophagy activation in an
NF-κB-independent manner.
Although the IKK family is composed of several members,
including IKKα, IKKβ, IKKγ, TBK1 and IKKε, the structure of
these factors is very similar25. Interestingly, one of these proteins,
TBK1, plays a pivotal role in controlling selective autophagy, such
as xenophagy and mitophagy6,23,47,49. Here, we demonstrated
that, in analogy with TBK1, which is mainly described to be
involved in the phosphorylation of the mitophagy receptor OPTN
upstream of its LIR motif in xenophagy23 and in mitophagy5,
IKKα is able to phosphorylate the mitophagy receptor AMBRA1
flanking its LC3-interacting region during mitochondrial clear-
ance. It seems that such mechanisms are evolutionary conserved
and we hypothesize that similar to OPTN, AMBRA1 could also
be involved in other selective autophagy processes (i.e.,
xenophagy).
It is noteworthy that IKKα is also fundamental in mitochon-
drial dynamics regulation by favouring OPA1 activation and
therefore mitochondrial fusion50. Moreover, Bakkar et al.51
demonstrated that IKKα regulates mitochondrial biogenesis in
muscle tissue. These data underline the complexity of IKKα
function, which seems to be highly related to inflammation,
mitochondria dynamics and mitophagy.
In sum, we prove that previously unravelled mitophagy-
involved proteins, HUWE1 E3 ubiquitin ligase and IKKα kinase,
play pivotal roles in AMBRA1-mediated mitophagy. HUWE1 is
crucial to trigger AMBRA1-mediated mitophagy by favouring
MFN2 degradation. This event is necessary for AMBRA1 phos-
phorylation on its S1014-mediated by IKKα. This kinase, in turn,
regulates the engulfment of damaged mitochondria into autop-
hagosomes by phosphorylating AMBRA1–S1014, thus enabling
AMBRA1–mATG8 interactions. Since either HUWE1 or IKKα
depletion inhibit mitophagy mediated by AMBRA1, we propose
that these two proteins strongly contribute to two different steps
in the AMBRA1-mediated mitophagy control (Fig. 8).
Finally, we demonstrated that AMBRA1, in a model of
ischaemia/re-oxygenation, regulates mitophagy together with
HUWE1 and IKKα, thus implying that AMBRA1-mediated
mitophagy plays a protective role in response to hypoxia. In the
same line, it would also be interesting to test whether Ambra1
heterozygous mice fail to show protection against ischaemic stress.
In sum, this work highlights this novel and alternative mito-
phagy pathway as a new target in developing therapy to coun-
teract diseases characterized by malfunctioning mitochondria
such as neurodegeneration, hypoxic-ischaemic encephalopathy
and cancer.
Methods
Antibodies. Antibodies used for western blot or immunofluorescence analysis are
listed in the Supplementary Table 1 with the appropriated dilutions.
Cell cultures and transfection. Cells were cultured in Dulbecco's modified Eagle's
medium (DMEM; GIBCO 41966-029) supplemented with 10% foetal bovine serum
(FBS; Thermo Fisher Scientific, 10270-106) and 1% penicillin–streptomycin solu-
tion (Lonza, 17-602 E) at 37 °C under 5% CO2. HeLa and SH-SY5Y cells were
purchased from Sigma-Aldrich (93021013 and 9403304, respectively). Penta-
knockout HeLa cells (Penta-KO) and mt-mKeima expressing wild-type or PINK1
knockout HeLa cells (mt-mKeima HeLa; mt-mKeima PINK1-KO) were a gift of R.
Youle5. HEK293T-HUWE1 cells were donated by T. Mak.
Transient transfections of expression plasmids into HeLa, Penta-KO,
HEK293T-HUWE1 and SH-SY5Y cells were performed using TurboFect or
Lipofectamine 2000 according to the supplier’s instructions (Thermo Fisher
Scientific, R0532; Invitrogene, 11668019).
Plasmids and cloning. All the transfected constructs presented in this article are
described in Supplementary Table 2.
Mutations listed in the Supplementary Table 3 were generated using the
QuickChange site-directed mutagenesis kit (Stratagene, 200519) and all plasmids
generated in this study were verified by DNA sequencing (Eurofins).
SiRNA-mediated knockdown. RNA-interference was performed using Lipo-
fectamine 2000. A list of siRNA constructs is described in Supplementary Table 4.
AMBRA1
mATG8
IKKα
P
CYTOSOL
HUWE1AM
BRA1
MNF2
?
HUWE1
UBMitochondrial 
membrane
depolarization
?
Proteasome
MNF2
S
10
14 L
IR
Fig. 8 AMBRA1 regulates mitophagy at two critical steps. Upon mitophagy stimulation, AMBRA1 mediates the HUWE1 E3 ubiquitin ligase translocation
from cytosol to mitochondria (light blue). AMBRA1 acts as a cofactor for HUWE1 E3 ubiquitin ligase activity, favouring its binding to its substrate MFN2
(and maybe other OMM substrates) and targeting it to the proteasome. This event is crucial and required for AMBRA1-induced mitophagy. In a second
step, in analogy with other mitophagy receptors, AMBRA1 is phosphorylated at S1014, flanking its LIR motif, in order to be able to interact with mATG8s.
The final outcome is the engulfment of damaged mitochondria (dark blue) into autophagosomes. This post-translational modification is controlled by IKKα
kinase upon mitophagy stimulation. Reproduced from ref.71 with permission from Elsevier
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Cell treatment. After 6 h of transfection or 24 h after cell seeding, cells were
treated as described below. Penta-KO were treated with the combined treatment O/
A (10 μM oligomycin (Calbiochem)/4 μM antimycin A (Sigma)), supplemented
with 20 μM QVD (Sigma-Aldrich, SML0063) in fresh growth medium for 24 h, as
in ref. 5. HeLa cells were treated either with the combined treatment O/A (2.5 and
0.8 μM) or FCCP 10 μM (Sigma-Aldrich, C2920) or EBSS (Thermo Fisher Scien-
tific, 24010043) for the indicated time. In order to block IKKα activity, cells were
treated with the irreversible inhibitor BAY-117082 at 1 or 2 μM, for the indicated
time. Autophagosome–lysosome fusion was blocked with NH4Cl 40 mM (Sigma-
Aldrich, O9718).
Western blot analysis. Cells were rinsed in phosphate-buffered saline (PBS) on
ice and lysed in RIPA buffer supplemented with a protease inhibitor cocktail
(Sigma-Aldrich, P8340), Na4VO3 0.1 mM (Sigma-Aldrich, S6508), NaF 1 mM
(Sigma-Aldrich, S7920) and β-Glycerophosphate 5 mM (Sigma-Aldrich, G6376).
Cell extracts were centrifuged at 15,000 × g for 10 min at 4 °C. Protein
concentrations were determined with the Bio-Rad Protein Assay Kit (Bio-Rad,
5000001). Cell extracts or immunoprecipitates were separated by sodium dodecyl
sulphate–polyacrylamide gel electrophoresis (SDS–PAGE). Polyvinylidene
difluoride (PVDF; Merck-Millipore, IPVH00010) or Nitrocellulose (GE Healthcare,
10600002) membranes were incubated with primary antibodies followed by
horseradish peroxidase-conjugate secondary antibodies (Bio-Rad, 1706515 and
1721011) and visualized with ECL (Merck-Millipore WBKLS0500). Uncropped
scans of the most important blots are reported in the Supplementary Information,
as Supplementary Figure 6.
Co-immunoprecipitation (Co-IP). After cell lysis, equal amounts of protein were
incubated with primary antibodies with end-over-end rotation for 24 h. Then, 30 µl
of protein A agarose beads (Roche, 11719408001) were added for 60 min. The
beads were collected by centrifugation and washed 3 times with the RIPA buffer.
Immunocomplexes were eluted with 30 µl of SDS sample buffer and heated at 95 °C
for 10 min.
Immunofluorescence analysis. Cells were washed in PBS and fixed with 4%
paraformaldehyde in PBS for 10 min. After permeabilization with 0.4% Triton X-
100 (Sigma-Aldrich, X-100) in PBS for 5 min, cells were incubated overnight at 4 °
C with primary antibodies and 2% normal goat serum (Sigma-Aldrich, G9023).
Cells were then washed with PBS (GIBCO, BE17-512F) and incubated for 1 h with
labelled anti-mouse (Thermo Fisher Scientific, A11017-A21425) or anti-rabbit
(Thermo Fisher Scientific, A11070-A21430-A31573) secondary antibodies. Nuclei
were stained with 1 μg/ml DAPI (4′,6-diamidino-2-phenylindole) and examined
under a Zeiss LSM 700 100× oil-immersion objective (CLSM700; Jena, Germany).
We used ImageJ software for image analysis. We calculated the mito content as
percentage of cytosolic area occupied by mitochondria with Mitophagy macro52.
For Supplementary Figure 1b, the quantification as mito-aggresome-positive
transfected cells (%) was performed by a blind approach (the information on
plasmid transfection was masked), counting the mitochondria with round and
clumped shape. All acquisitions were performed in non-saturated single z-confocal
planes.
Nuclei–mitochondria–cytosol purification. Cells, rinsed in ice-cold PBS and
centrifuged at 800 × g for 10 min, were resuspended in homogenization buffer (HB:
0.25M sucrose (Sigma-Aldrich, S0389), 10 mM HEPES pH 7 (Sigma-Aldrich,
H4034), EDTA (Sigma-Aldrich, ED-100)) with protease and phosphatase inhibi-
tors cocktail. Nuclei, mitochondria and cytosol purifications proceed by standard
differential centrifugations. After homogenization of the solution with 30–70 pulses
(one pulse corresponds to approximately 1 s), cells were collected at 600 × g at 4 °C
for 10 min. The pellet containing the nuclear fraction was suspended in RIPA
buffer, instead the supernatant was subjected to a further centrifugation at
11,000 × g for 15 min at 4 °C. The mitochondrial pellet fraction was suspended in
RIPA buffer. The supernatant fraction corresponded to soluble cytosolic proteins.
In vitro IP-kinase assay. HeLa cells were transiently transfected with a vector
encoding for Myc-AMBRA1WT or Flag-IKKαWT or HA-IKKαK44M. After 24 h,
equal amounts of proteins (500 µg) were immunoprecipitated using anti-Myc, anti-
Flag and anti-HA antibodies, respectively, overnight. Protein A Agarose beads (30
µl of 50% slurry) (Roche, 11719408001) were added to the samples at 4 °C with
end-over-end rotation for 1 h. The immunoprecipitates were collected by cen-
trifugation and washed 3 times with RIPA buffer. Pellets were washed for 3 min
with 500 µl 1× Kinase Buffer (KB: 20 mM Hepes pH 7.4, 10 mM MgCl2, 25 mM
Glycerophosphate, 0.1 Na4VO3, 4 mM NaF, 1 mM DTT (Sigma-Aldrich, GE17-
1318-01)). The IP-Flag- IKKαWT or IP-HA-IKKαK44M final pellets were resus-
pended in 50 µl of 1× Kinase Buffer, while IP-Myc-AMBRA1 was suspended in 50
µl of RIPA buffer. In order to test kinase activity with a non-radioactive method, 1
µl of 10 mM adenosine triphosphate (ATP) and 20 µl of IP-Myc-AMBRA1 sub-
strate were added to the IP kinases for 30 min at 30 °C. The reaction was stopped
by adding 30 µl of 4× SDS Sample Buffer and denaturizing at 95 °C for 5 min. For
the kinase assay with recombinant AMBRA1, the wild-type AMBRA1 protein was
transcribed and translated in vitro with standard procedures (Promega, L1170
TnT® Quick Coupled Transcription/ Translation Systems). At the end of IKKαWT
or IKKαK44M immunoprecipitation (as described above), 1 µl of 10 mM ATP and 2
µl of kinase substrate was added to the IP-kinases for 30 min at 30 °C. The reaction
was stopped by adding 30 µl of SDS Sample Buffer and denaturizing at 95 °C for 5
min. For both of these kinase assays, samples were analysed by western blot.
Isothermal titration microcalorimetry. The ITC experiments were performed at
25 °C and 35 °C using a MicroCal VP-ITC microcalorimeter (Malvern Instruments
Ltd, UK). The peptides at concentrations of 0.35 mM were titrated into 0.015 mM
LC3 and GABARAP proteins in 21 steps. The ITC data were analysed with the
ITC-Origin 7.0 software with a one-site binding model. The protein and peptide
concentrations were calculated from the UV absorption at 280 nm through a
Nanodrop spectrophotometer (Thermo Fisher Scientific, DE, USA).
NMR spectroscopy. All NMR experiments were performed at 298 K on Bruker
Avance spectrometer operating at a proton frequencies of 600MHz. Titration
experiments were performed with 0.17 mM 15N-labelled LC3B and GABARAP
protein samples to which the non-labelled AMBRA1-LIR peptides were added
stepwise until 8 times excess to LC3B protein, or 4 times excess to the GABARAP
protein. Chemical shift perturbations (CSP) analysis was done according to the
most recent review53. CSP values were calculated for each individual backbone
proton using the formula: Δδ= [ΔδH2+ (ΔδN/5)2]1/2. The dissociation constants,
KD, were calculated by a least squares fit to the titration data under the assumptions
of a fast exchange regime and a one binding site mode of the protein interaction.
The obtained CSP values were mapped on LC3B (PDB ID 1UGM54) and
GABARAP (PDB ID 1GNU55) structures.
ITC and NMR sample preparation. For ITC and NMR experiments, the unla-
belled or 15N-labelled LC3 and GABARAP proteins were obtained based on the
protocols described elsewhere56,57. AMBRA1-LIR-containing peptides with dif-
ferent states of S1014 phosphorylation (unphosphorylated, P0: EALNSG-
VEYYWDQLNET; D-phosphomimicked, PM: EALNDGVEYYWDQLNET; and
S1014 phosphorylated, P1: EALN{pS}GVEYYWDQLNET) were purchased from
GenScript Inc. (NJ, USA). Before experiments, all proteins and peptides were
equilibrated with a buffer containing 50 mM Na2HPO4, 100 mM NaCl, pH 7.0; and
supplemented with 5 mM protease inhibitor cocktail.
AMBRA1–LC3B modelling. We used Modeller version 9.1558 to generate struc-
tural models of the AMBRA1-LIR motif (L1013NSGVEYYWDQLNET1026) in
complex with LC3B to use as starting structures for the all-atom MD simulations.
For the modelling, we used the X-ray structure of p62-LIR motif in complex with
LC3B (PDB entry 2ZJD)59 as a template. We generated 1000 binding poses with
Modeller and we then carried out structural clustering with the linkage algorithm
based on the root mean square deviation (RMSD) of all the atoms of Ambra1-LIR
peptide. We selected the average structures from each of the four more populated
clusters (i.e., the conformer with the lowest RMSD to the other ones in the same
cluster) and we used each of them as a starting structure for all-atom explicit
solvent molecular simulations using multiple replicates. For the phosphorylated
variant of Ambra1-LIR, we generated a second set of models by in silico phos-
phorylation (S2P; phosphoserine with a −2 charge) on position S1014 in each of
the four models previously selected using the web interface of Vienna-PTM60. We
treated in our simulation the phosphoserine S1014 using the −2 state. Indeed, the
pKa values of single protonated/un-protonated transition of phosphoserine suggest
that both states are present at neutral pH, but the −2 state is predominant61.
We carried out 250-ns all-atom MD simulations in explicit solvent for each of
the selected four models in both unphosphorylated and phosphorylated states, as
well as a simulation of the known LC3B-p62 complex as a reference. The MD
simulations were performed with Gromacs version 5.162 with the protein force
fields Charmm22/CMAP63 and Charmm22*64 in conjunction with the TIPS3P
water model. Parameters for S2P were merged from ref. 65. All systems were
solvated in dodecahedral boxes with a minimum distance between protein and box
edge of 1.8 nm and charged ions were added to set a concentration of 0.15M NaCl.
The productive MD simulations were carried out at 298 K with simulation
parameters and equilibration protocol66. The first 50 ns of each MD simulation
required for equilibration of the system was discarded from downstream analyses.
For each trajectory we calculated, as a measure of protein flexibility, the average
RMSF for each Cα atom in the Ambra1-LIR or the p62-LIR peptides averaging the
RMSF over 10-ns time windows and estimating the associated standard deviations.
The four independent replicates of each system were merged into a
concatenated trajectory for the analyses of electrostatic interactions.
We estimated intra- and inter-molecular electrostatic interactions, as
implemented in the PyInteraph suite of tools67. The interactions are defined as
distances between the charged groups in the residue side chains of arginine, lysine,
aspartate, glutamate and the phosphoserine. We employed a 5 Å cutoff in the
analyses. To filter out interactions with low occurrence in the simulations, we
included in the final networks only those interactions which are present in at least
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20% of the simulation frames, as previously tested in other cases of study67. All the
electrostatic interactions identified for each of the MD ensembles were visualized
using the PyMOL plugin xPyder68.
Mass spectrometry analysis of AMBRA1-interacting proteins. SILAC-based
strategy is used for comparative and quantitative AMBRA1-interacting proteins
analysis in HeLa cells in mitophagy condition. Cells were growth in SILAC DMEM
(Silantes, 280001200), supplemented with FBS 10%, 1% penicillin–streptomycin
solution, L-glutamine, L-arginine and L-lysine, according to the supplier’s instruc-
tions. Accordingly, we obtained two different isotope amino-acid labelling media:
Light Medium K0/R0 and SILAC Heavy medium (K6/R10). Cells were growth in
these media for 2 weeks.
In order to analyse AMBRA1 interactors during mitophagy, Light and Heavy
cells were transfected with a vector encoding for Myc-AMBRA1ActA for 24 h. Equal
amounts of harvested Light and Heavy lysates were immunoprecipitated with an
anti-Myc antibody, as previously described in the immunoprecipitation protocol.
Immunoprecipitated heavy proteins were then mixed 1:1 with light proteins and
subjected to SDS–PAGE followed by band excision and trypsin-peptide digestion
in order to allow LC-ESI-MS/MS (liquid chromatography-electrospray ionization-
tandem mass spectrometry) analysis15.
In vitro ubiquitylation assay. HEK293T cells stably expressing Flag-HUWE1 were
lysed with Triton Buffer (50 mM Tris-Hcl pH 7.5, 250 mM NaCl, 50 mM NaF,
1 mM EDTA 1 pH 8, 0,1% Triton), supplemented with proteases and phosphatases
inhibitors. Then, 3–5 mg of whole cell lysates were precleared with protein A/G-
Sepharose beads (GE Healthcare) for 3 h and then incubated overnight at 4 °C with
5 mg of anti-Flag antibody (Sigma-Aldrich, F3165) per sample. Finally, the
immunocomplexes have been absorbed on protein A/G-Sepharose beads, washed
six times in Triton lysis buffer and used for in vitro ubiquitylation assay or eluted
by boiling in SDS loading buffer.
In vitro ubiquitylation assay was carried out using HUWE1 complex
immunopurified from HEK293T cells stably expressing Flag-HUWE1 using the
method described above. The beads containing the HUWE1 immunocomplexes
were washed twice with equilibration buffer (25 mM Tris-Hcl pH 7.5, 50 mM NaCl,
1 mM EDTA, 0.01% Triton and 10% glycerol) and then added to the following
reaction: 40 ng of E1, 0.5 μg of UbcH3, 0.5 μg of UbcH5, 0.3 μg of UbcH7, 1 μg of
ubiquitin in the ubiquitylation buffer (2.5 mM Tris·HCl, 0.7 mM dithiothreitol
(DTT), 4 mM ATP, 10 mM MgCl2, 0.1 mM ubiquitin aldehyde) in a final volume
of 30 μl. The assays have been carried out for 90 min at 30 °C, then the
immunocomplexes were eluted by boiling in SDS loading buffer, loaded on
SDS–PAGE, blotted onto PVDF membranes (Millipore) and then blocked with
PBS-T (phosphate-buffered saline and 0.1% Tween-20) containing 5% non-fat dry
milk for 1 h at room temperature (RT). The incubation with primary antibodies
was performed for 2 h at RT, followed by appropriate horseradish peroxidase-
conjugated secondary antibodies for 1 h at RT. After extensive washing, detection
was performed with the ECL Western Blot Chemiluminescence Reagent (Perkin
Elmer).
In vitro protocols of ischaemia. Preconditioning and ischaemia condition were
recreated by exposing cells to 30 min and 3 h, respectively, of OGD69. In addition,
cells were exposed to 1 h of OGD. Initially, OGD was performed in a medium
previously satured with 95% N2 and 5% CO2 for 20 min and containing NaCl
116 mM, KCl 5.4 mM, MgSO4 0.8 mM, NaHCO3 26.2 mM, NaH2PO4 1 mM, CaCl2
1.8 mM, glycine 0.001 mM and 0.001 w/v phenol red33,70. Then, hypoxic condi-
tions were maintained using a hypoxia chamber at 37 °C, 5% CO2 and 95% N2. At
the end of OGD, the cells were incubated for 24 h in normoxic conditions using
DMEM containing normal levels of O2 in a CO2 incubator at 37 °C RX) followed
by lysis for western blot analysis. Whole cell lysate were prepared in RIPA buffer
(50 mM Tris-HCl, 150 mM NaCl, 1% (v/v) Triton X-100, pH 8.0) containing
protease and the phosphatase inhibitors.
mt-mKeima mitophagy assay. Wild-type and PINK1-KO HeLa cells stably
expressing mitochondrial-targeted mKeima (mt-mKeima,7) were co-transfected
with PcDNA3+GFP, Myc-AMBRA1WT+GFP, Myc-AMBRA1S1014A+GFP, Myc-
AMBRA1S1014D+GFP, PcDNA3+GFP-ShCtr, Myc-Ambra1ActA+GFP-ShCtr or
myc-Ambra1ActA+GFP-ShHUWE1, and treated as indicated in the text. GFP was
used as a reporter for co-transfected cells. Live cells were photographed at 37 °C/5%
CO2 through the live cell imaging microscope UltraView Vox (Perkin Elmer). mt-
mKeima was excited both at 405 nm (neutral, pseudo-coloured in green) and
561 nm (acidic, red) and detected through the same emission filter (615 nm, W70),
while GFP was captured with standard procedures (488 nm excitation, 525 nm
W50 emission filter, pseudo-coloured in cyan). A total of 100 randomized fields per
condition were detected in each experiment with a 100× objective. Randomization
was performed through an automated function of the miscroscope. mt-mKeima
fluorescence intensity was quantified in single GFP-positive cells with the inte-
grated function of the microscope software Volocity (Perkin Elmer). Fields with no
GFP-positive cells were excluded from the analysis.
Statistical analysis. All statistical calculations were performed and graphed using
GraphPad Prism 6. Comparisons between two groups were analysed using Stu-
dent’s t-test assuming a two-tailed distribution. Three or more group comparisons
were performed with one-way analysis of variance (ANOVA) and Tukey’s post-test
with a confidence interval of 95%. Significance is defined as *P < 0.05; **P < 0.01;
***P < 0.001; ****P < 0.0001. No statistical methods were used to predetermine
sample size.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request.
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